Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy
Sign Up to like & getrecommendations! Published in 2017 at "Modern Rheumatology"
DOI: 10.1080/14397595.2016.1214340
Abstract: Abstract Objective: To investigate the reliable markers reflecting treatment response better than the traditional inflammatory indices in patients with rheumatoid arthritis (RA) receiving tocilizumab therapy. Methods: A total of 58 RA patients treated with tocilizumab… read more here.
Keywords: treatment response; tocilizumab therapy; neutrophil lymphocyte; lymphocyte ratio ... See more keywords
Interrupting tocilizumab therapy‐induced psoriasis‐like eruption in a patient with rheumatoid arthritis and Crohn's disease
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Dermatology"
DOI: 10.1111/ijd.14809
Abstract: References 1 Neri I, Dondi A, Ricci L, et al. Baboon-like syndrome in children. Pediatr Dermatol 2014; 31: e73–e75. 2 Andersen KE, Hjorth N, Menn e T. The baboon syndrome: systemically-induced allergic contact dermatitis. Contact… read more here.
Keywords: tocilizumab therapy; eruption; baboon syndrome; interrupting tocilizumab ... See more keywords
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
Sign Up to like & getrecommendations! Published in 2019 at "Turkish Journal of Medical Sciences"
DOI: 10.3906/sag-1906-39
Abstract: Background/aim Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional immunosuppressive agents. The aim of this study is to assess… read more here.
Keywords: tocilizumab therapy; therapy; real life; anti interleukin ... See more keywords